ODDB.org: Open Drug Database

Bayer (Schweiz) AG - Xarelto vascular 2,5 mg, Filmtabletten

Swissmedic Registration	66872	Sequence	01
Product name	Xarelto vascular 2,5 mg	Description	Filmtabletten
ATC-Classification	B01AF01	ATC-Description	Rivaroxaban
Introduction of Sequence	05.04.2019

Composition

rivaroxabanum 2.5 mg, cellulosum microcristallinum, carmellosum natricum conexum, hypromellosum, lactosum monohydricum 36 mg, magnesii stearas, natrii laurilsulfas, Überzug: hypromellosum, macrogolum 3350, E 171, E 172 (flavum), pro compresso obducto corresp. natrium 0.6 mg.

Packungsbestandteile

Galenic Form

Coated tablets

Active Agent	Dose
Rivaroxabanum	2.5 mg

BAG: Active Agent	Dose
Rivaroxabanum	2.5 mg

Inactive agents	Dose	additional_information
(Flavum)
Carmellosum Natricum Conexum
Cellulosum Microcristallinum
E 171		color.
E 172		color.
Hypromellosum		Überzug
Lactose Monohydrate	36 mg
Macrogol	3350
Magnesii Stearas
Natrii Laurilsulfas
Pro Compresso Obducto

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
002	56	31.56	50.45	B	SL	No
003	196	110.49	135.55	B	SL	No
005	100			B		No
006	30 x 1			B		No

2025	©ywesee GmbH